Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...

The Food and Drug Administration (FDA) announced on Thursday that it authorized the marketing of Zyn nicotine pouches but ...

The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...

The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine ...

FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...

The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.

Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive ...

The agency finds Zyn’s benefit as a safer alternative for adult cigarette smokers outweighs its risk to young people.

The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs.

Marketing for the popular nicotine pouch product, Zyn, has been approved by the U.S. Food and Drug Administration to help ...

The Food and Drug Administration has authorized the sales of 20 types of ZYN nicotine pouches amid concerns about children ...